After confirming the disease burden histologically in mice, we detected the level of ARL6IP5 in the human brain sections and were excited to see the decrease (85 ± 28%, p = 0.0042, n = 3) in its level in the PD patients’ brain samples as compared to healthy controls (Figure 1C,D). This evidence concerns the gene ARL6IP5 and Parkinson disease.